1
|
Shapiro YN, Peppercorn JM, Yee AJ, Branagan AR, Raje NS, Donnell EKO. Lifestyle considerations in multiple myeloma. Blood Cancer J 2021; 11:172. [PMID: 34702799 PMCID: PMC8548591 DOI: 10.1038/s41408-021-00560-x] [Citation(s) in RCA: 11] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/20/2021] [Revised: 09/08/2021] [Accepted: 10/01/2021] [Indexed: 12/12/2022] Open
Abstract
As the prognosis for multiple myeloma (MM) has significantly improved and patients remain on therapy longer, there is a need for supportive care interventions to optimize patient quality of life (QOL) and functional status over the course of cancer treatment. MM is characterized by a significant symptom burden and a relatively lower QOL compared to other cancers. This review evaluates the role of healthy lifestyle behaviors in improving both the physical functioning and psychological well-being of the MM population. We (1) describe the current literature on physical activity, weight management, diet, sleep, and substance use in the context of MM, (2) present important considerations for incorporating lifestyle factors into clinical practice, and (3) identify directions for future research. Developing MM-specific guidelines for modifiable lifestyle changes that take into account both the length of treatment and the unique disease features (i.e. osteolytic lesions and anemia) may provide a promising path for improved patient QOL and functioning.
Collapse
Affiliation(s)
| | - Jeffrey M Peppercorn
- Massachusetts General Hospital, Boston, MA, USA.,Harvard Medical School, Boston, MA, USA
| | - Andrew J Yee
- Massachusetts General Hospital, Boston, MA, USA.,Harvard Medical School, Boston, MA, USA
| | - Andrew R Branagan
- Massachusetts General Hospital, Boston, MA, USA.,Harvard Medical School, Boston, MA, USA
| | - Noopur S Raje
- Massachusetts General Hospital, Boston, MA, USA.,Harvard Medical School, Boston, MA, USA
| | - Elizabeth K O' Donnell
- Massachusetts General Hospital, Boston, MA, USA. .,Harvard Medical School, Boston, MA, USA.
| |
Collapse
|
2
|
Borsi E, Serban CL, Potre C, Potre O, Putnoky S, Samfireag M, Tudor R, Ionita I, Ionita H. High Carbohydrate Diet Is Associated with Severe Clinical Indicators, but Not with Nutrition Knowledge Score in Patients with Multiple Myeloma. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2021; 18:ijerph18105444. [PMID: 34069672 PMCID: PMC8161065 DOI: 10.3390/ijerph18105444] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 04/18/2021] [Revised: 05/14/2021] [Accepted: 05/17/2021] [Indexed: 12/16/2022]
Abstract
Although the survival rate of patients diagnosed with multiple myeloma has doubled over the last few decades, due to the introduction of new therapeutic lines and improvement of care, other potential contributors to the therapeutic response/relapse of disease, such as nutrient intake, along with nutrition knowledge, have not been assessed during the course of the disease. The purpose of this research was to assess nutrition knowledge and diet quality in a group of patients with a diagnosis of multiple myeloma. Anthropometric, clinical and biological assessments and skeletal survey evaluations, along with the assessment of nutritional intake and general nutrition knowledge, were performed on 61 patients with a current diagnosis of multiple myeloma. A low carbohydrate diet score was computed, classified in tertiles, and used as a factor in the analysis. Patients in tertiles indicative of high carbohydrate or low carbohydrate intake showed significant alteration of clinical parameters, such as hemoglobin, uric acid, albumin, total proteins, beta-2 microglobulin, percentage of plasmacytes in the bone marrow and D-dimers, compared to patients in the medium carbohydrate intake tertile. Nutrition knowledge was not associated with clinical indicators of disease status, nor with patterns of nutrient intake. Better knowledge of food types and nutritional value of foods, along with personalized nutritional advice, could encourage patients with MM to make healthier decisions that might extend survival.
Collapse
Affiliation(s)
- Ema Borsi
- Discipline of Hematology, Department of Internal Medicine, Victor Babes University of Medicine and Pharmacy, 300041 Timisoara, Timis County, Romania; (E.B.); (C.P.); (O.P.); (I.I.); (H.I.)
| | - Costela Lacrimioara Serban
- Department of Functional Science, Victor Babes University of Medicine and Pharmacy, 300041 Timisoara, Timis County, Romania
- Correspondence: (C.L.S.); (S.P.); Tel.: +40-770-198-363 (C.L.S.)
| | - Cristina Potre
- Discipline of Hematology, Department of Internal Medicine, Victor Babes University of Medicine and Pharmacy, 300041 Timisoara, Timis County, Romania; (E.B.); (C.P.); (O.P.); (I.I.); (H.I.)
- Hematology Clinic, Timisoara’s Emergency City Hospital, 300723 Timisoara, Timis County, Romania;
| | - Ovidiu Potre
- Discipline of Hematology, Department of Internal Medicine, Victor Babes University of Medicine and Pharmacy, 300041 Timisoara, Timis County, Romania; (E.B.); (C.P.); (O.P.); (I.I.); (H.I.)
- Hematology Clinic, Timisoara’s Emergency City Hospital, 300723 Timisoara, Timis County, Romania;
| | - Salomeia Putnoky
- Department of Microbiology, Victor Babes University of Medicine and Pharmacy, 300041 Timisoara, Timis County, Romania;
- Correspondence: (C.L.S.); (S.P.); Tel.: +40-770-198-363 (C.L.S.)
| | - Miruna Samfireag
- Hematology Clinic, Timisoara’s Emergency City Hospital, 300723 Timisoara, Timis County, Romania;
- Department of Internal Medicine, Discipline of Clinical Practical Skills, Victor Babes University of Medicine and Pharmacy, 300041 Timisoara, Timis County, Romania
| | - Raluca Tudor
- Department of Neurology, Victor Babes University of Medicine and Pharmacy, 300041 Timisoara, Timis County, Romania;
| | - Ioana Ionita
- Discipline of Hematology, Department of Internal Medicine, Victor Babes University of Medicine and Pharmacy, 300041 Timisoara, Timis County, Romania; (E.B.); (C.P.); (O.P.); (I.I.); (H.I.)
- Hematology Clinic, Timisoara’s Emergency City Hospital, 300723 Timisoara, Timis County, Romania;
| | - Hortensia Ionita
- Discipline of Hematology, Department of Internal Medicine, Victor Babes University of Medicine and Pharmacy, 300041 Timisoara, Timis County, Romania; (E.B.); (C.P.); (O.P.); (I.I.); (H.I.)
- Hematology Clinic, Timisoara’s Emergency City Hospital, 300723 Timisoara, Timis County, Romania;
| |
Collapse
|
3
|
Snowden JA, Greenfield DM, Bird JM, Boland E, Bowcock S, Fisher A, Low E, Morris M, Yong K, Pratt G. Guidelines for screening and management of late and long-term consequences of myeloma and its treatment. Br J Haematol 2017; 176:888-907. [PMID: 28107574 DOI: 10.1111/bjh.14514] [Citation(s) in RCA: 35] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Abstract
A growing population of long-term survivors of myeloma is now accumulating the 'late effects' not only of myeloma itself, but also of several lines of treatment given throughout the course of the disease. It is thus important to recognise the cumulative burden of the disease and treatment-related toxicity in both the stable and active phases of myeloma, some of which is unlikely to be detected by routine monitoring. We summarise here the evidence for the key late effects in long-term survivors of myeloma, including physical and psychosocial consequences (in Parts 1 and 2 respectively), and recommend the use of late-effects screening protocols in detection and intervention. The early recognition of late effects and effective management strategies should lead to an improvement in the management of myeloma patients, although evidence in this area is currently limited and further research is warranted.
Collapse
Affiliation(s)
- John A Snowden
- Department of Haematology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.,Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK
| | - Diana M Greenfield
- Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK.,Department of Oncology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK
| | - Jennifer M Bird
- University Hospitals Bristol NHS Foundation Trust, Bristol, UK
| | - Elaine Boland
- Palliative Medicine, Queen's Centre for Oncology and Haematology, Hull and East Yorkshire Hospitals NHS Trust, Hull, UK
| | - Stella Bowcock
- King's College Hospital NHS Foundation Trust, London, UK
| | | | | | | | - Kwee Yong
- University College London, London, UK
| | - Guy Pratt
- University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
| | | |
Collapse
|